An Evaluation Of Sagimet Biosciences Inc (NASDAQ: SGMT) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Stocks Info

SGMT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Sagimet Biosciences Inc is $119.77M. A total of 0.78 million shares were traded on the day, compared to an average of 1.74M shares.

In the most recent transaction, Happel David bought 12,100 shares of SGMT for 5.27 per share on Mar 26 ’24. After the transaction, the President & CEO now owns 639,200 company shares. In a previous transaction on Dec 07 ’23, Happel David bought 1,600 shares at 4.10 per share. SGMT shares that President & CEO owns now total 627,100.

Among the insiders who bought shares, Happel David acquired of 590 shares on Nov 16 ’23 at a per-share price of $2.35. This resulted in the President & CEO holding 590 shares of SGMT after the transaction. In another insider transaction, SEIDENBERG BETH C bought 46,875 shares at $16.00 per share on Jul 18 ’23. Company shares held by the Director now total 46,875.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SGMT has a high of $20.71 and a low of $2.13.

As of this writing, SGMT has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.51. The company reported an EPS of -$0.35 in the last quarter, which was 64.60% higher than expectations of -$0.99.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SGMT’s latest balance sheet shows that the firm has $56.73M in Cash & Short Term Investments as of fiscal 2021. There were $348.00k in debt and $2.44M in liabilities at the time. Its Book Value Per Share was $3.98, while its Total Shareholder’s Equity was -$158.26M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SGMT is Buy with a score of 5.00.

Most Popular

Related Posts